Nan Jiang, M.D, Ph.D.
Title
Professor of Surgery
Research Interests
· Liver transplantation
· The mechanism of HCC recurrence and metastasis
· Liver tissue injury and preservation
· Immunosuppressants individualized
· Clinical outcomes analyses
My research is focusing on HCC recurrence and metastasis, targeted siRNA gene therapy for liver injury and preservation, application of gene chip to guide immunosuppressant individualized in organ transplant patients and gene diagnosis.
Education and Experience
· M.D., Chang zhi Medical University, Medicine(2000)
· M.Sc., Kun Ming Medical University, Surgery(2003)
· Ph.D., Sun Yat-Sen University, Surgery(2006)
· Residency ,University of Sun Yat-Sen University - Surgery (2006)
· Attending , University of Sun Yat-Sen University- Surgery (2008)
· Postdoctoral,Multi-Organ Transplant Program of University of Western Ontario (2009)
· Assocaite Professor ,University of Sun Yat-Sen University- Surgery (2010)
· Professor ,University of Sun Yat-Sen University- Surgery (2015)
Honors and Awards
23 th World Transplant Congress -Emerging economy travel award (2010)
Advances in Organ Transplantation-Genzyme Annual Fellows Conference, (2010)
Publications
1 Nan Jiang,Wen-Jie Chen,Jian-Wen zhang,Chi Xu, Xian-Cheng Zeng,Tong Zhang,Yang Li,Guo-Ying Wang(*).Downregulation of miR-432 ActivatesWnt/β-catenin Signaling and Promotes Human Hepatocellular Carcinoma Proliferation. Oncotarget,2015,6(10):7866-7879.
2 Jiang N, Zhang X, Zheng X, Chen D, Zhang Y, Siu LK, Xin HB, Li R, Zhao H, Riordan N, Ichim TE, Quan D, Jevnikar AM, Chen G, Min W(*).Targeted Gene Silencing of TLR4 Using Liposomal Nanoparticles for Preventing Liver Ischemia Reperfusion Injury.Am J Transplant , 2011,11(9):1835-1844.
3 Xian-Cheng Zeng,Fo-Qiu Liu,Rong Yan,Hui-Min Yi,Tong Zhang,Guo-Ying Wang,Yang Li, Nan Jiang(*). Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma. Molecular Cancer, 2014,13:261.
4 Shu-Peng Chen, Luo-Sheng Zhang, Bin-Sheng Fu, Xian-Cheng Zeng, Hui-Min Yi, Nan Jiang(*). Prostate Tumor Overexpressed 1 Is a Novel Prognostic Marker for Hepatocellular Carcinoma Progression and Overall Patient Survival. Medicine (Baltimore), 2015,94(4):e423.
5 Nan Jiang, Xusheng Zhang, Xiufen Zheng, Di Chen, Kingsun Siu, Hongmei Wang,Thomas E. Ichim, Douglas Quan, Vivian McAlister, Guihua Chen, Wei-Ping Min(*).A Novel In Vivo siRNA Delivery System Specifically Targeting Liver Cells for Protection of ConA-Induced Fulminant Hepatitis. PLoS One ,2012, 7(9):e44138.
6 De-Hao Huang, Guo-Ying Wang, Jian-Wen Zhang, Yang Li,Xian-Cheng Zeng,Nan Jiang(*) .MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma. Jpn J Clin Oncol.2015 45(8):738-44.
7 Yang Li, Dan-Yun Ruan, Hui-Min Yi, Guo-Ying Wang, Yang Yang, Nan Jiang(*).A three-factor preoperative scoring model predicts risk of recurrence following liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function. Hepatobiliary & Pancreatic Diseases International (HBPD INT),2015 14(5):477-84.
8 Nan Jiang(*),Wei Chen,Jian-wen zhang,Yang Li,Tong Zhang, Bin-Sheng Fu, Hui-Min Yi,Qi Zhang .Aberrantly regulated dysadherin and Bcl-2/Bax2 enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells. Molecular Medicine Reports,2015,12(5):7239-46.
9 Jian-wen zhang, Yang Li, Xian-Cheng Zeng, Tong Zhang, Bin-Sheng Fu, Hui-Min Yi,Qi Zhang, Nan Jiang(*).miR-630 overexpression in hepatocellular carcinoma tissues is positively correlated with alpha-fetoprotein. Med Sci Monit, 2015,21:667-673.
10 Nan Jiang, Hua LI, Gen-Shu Wang, Jian Zhang, Jun-Feng Zhang, Shu-Hong Yi, Yang Yang,Chang-Jie Cai, Min-Qiang Lu, Gui-Hua Chen. Acute Leukemia, a Rare but Fatal Complication After Liver Transplantation. Leukemia Research, 2009, 33 (10):1349–1351.
Contact
The Third Affiliated Hospital of Sun Yat-Sen University
No.600, TianHe Road, Guangzhou, 510630
Tel: 86-20-85252185
Cell phone : 86-13126479091
Fax: 86-20-85252276
E-mail:njiang163@163.com
